Synaptogenix, Inc.
SNPX
$2.50
$0.09023.74%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.21M | 5.01M | 5.09M | 5.38M | 6.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.81M | 6.76M | 6.83M | 7.08M | 8.31M |
| Operating Income | -6.81M | -6.76M | -6.83M | -7.08M | -8.31M |
| Income Before Tax | -12.77M | -8.22M | -1.71M | -4.53M | -6.04M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.77 | -8.22 | -1.71 | -4.53 | -6.04 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.77M | -8.22M | -1.71M | -4.53M | -6.04M |
| EBIT | -6.81M | -6.76M | -6.83M | -7.08M | -8.31M |
| EBITDA | -6.81M | -6.76M | -6.83M | -7.08M | -8.31M |
| EPS Basic | -10.34 | -7.63 | -3.89 | -37.38 | -43.56 |
| Normalized Basic EPS | -4.69 | -4.24 | -0.41 | -8.43 | -11.87 |
| EPS Diluted | -10.34 | -7.63 | -3.89 | -37.38 | -43.56 |
| Normalized Diluted EPS | -4.69 | -4.24 | -0.41 | -8.43 | -11.87 |
| Average Basic Shares Outstanding | 4.92M | 4.41M | 3.52M | 2.61M | 1.87M |
| Average Diluted Shares Outstanding | 4.92M | 4.41M | 3.52M | 2.61M | 1.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -7.45% | -11.57% | -0.01% | -14.14% | -10.62% |